Audiologists in Somerset, NJ Accepting Medicare
10 Audiologists found. Showing 1 - 10
 Hearinglife Audiologist Medicare: Medicare Enrolled Practice Location: 2501 Cottontail Ln, Somerset, NJ 08873 Phone: 877-857-7487 |
 Ms. Maureen A Doty, MA, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 29 Schoolhouse Rd, Somerset, NJ 08873 Phone: 732-560-1220 Fax: 732-748-2011 |
Hearinglife Texas, Llc Audiologist Medicare: Medicare Enrolled Practice Location: 2501 Cottontail Ln, Somerset, NJ 08873 Phone: 732-564-7115 |
Dr. Laura Ann Galasso-coons, AUD. CCC-ASLP Audiologist Medicare: Accepting Medicare Assignments Practice Location: 37 Clyde Rd, Somerset, NJ 08873 Phone: 732-873-6863 |
Ellen L Cooperider Audiologist Medicare: Medicare Enrolled Practice Location: 2501 Cottontail Ln, Somerset, NJ 08873 Phone: 732-529-7120 |
Accuquest Hearing Center, Llc Audiologist Medicare: Medicare Enrolled Practice Location: 2501 Cottontail Ln, Somerset, NJ 08873 Phone: 609-285-9893 |
Your Hearing Network, Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 580 Howard Ave, Somerset, NJ 08873 Phone: 732-529-7193 |
Hear Better Centers, Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2501 Cottontail Ln, Somerset, NJ 08873 Phone: 732-564-7115 |
Dr. Candace Matthews Depp, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 580 Howard Ave, Somerset, NJ 08873 Phone: 908-635-7803 |
Dr. Faith Marlene Mogila, SCD Audiologist Medicare: Medicare Enrolled Practice Location: 37 Clyde Rd, Suite 103, Somerset, NJ 08873 Phone: 732-873-6863 Fax: 732-873-6853 |
News Archive
arGEN-X and Shire achieve milestone in SIMPLE Antibody R&D collaboration
arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it has attained a key success milestone in its SIMPLE Antibody research and product development collaboration with the Human Genetic Therapies division of Shire Pharmaceuticals. The milestone, which triggered an undisclosed payment from Shire, was the first demonstration of in vivo proof of concept for one of the antibody discovery programs undertaken in the collaboration.
MPI Research lauds FDA's current guidance on abuse potential of drugs
On January 26, 2010, the Food and Drug Administration (FDA) released a key draft guidance document, Guidance for Industry Assessment of Abuse Potential of Drugs. When finalized, this guidance will represent the FDA's current position on the abuse potential of drugs. Noteworthy within the document, Good Laboratory Practices (GLP) specified in the Guidance for Industry S7A Safety 471 Pharmacology Studies for Human Pharmaceuticals and in FDA regulations, 21 CFR 472 part 58, now also apply to abuse potential studies in animals.
Flinders University trial to evaluate new blood test for personalized cancer treatment
A blood test to help guide the treatment of oesophageal, stomach and bowel cancers will be evaluated in a new Flinders University trial set to get underway.
U.S. Supreme Court agrees to hear Teva Pharmaceutical's appeal related to COPAXONE patent
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced that the U.S. Supreme Court has granted the Company's COPAXONE® certiorari petition and will hear its appeal of a decision from the United States Court of Appeals for the Federal Circuit that invalidated the claim of U.S. Patent 5,800,808 (the "'808 patent").
› Verified 5 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Chiropractors
Optometrists
Podiatrists
Audiologists